LDS/Medical Tests/MYH7 Gene Mutation Analysis

MYH7 Gene Mutation Analysis

The MYH7 gene is located on chromosome 14 at position 11.2 and encodes cardiac myosin heavy chain 7 beta subunit (MHC-β). The β isoform of myosin heavy chain is the major isoform in the human ventricle and in slow-twitch skeletal fibers. It is the major protein comprising the thick filaments in cardiac muscle and plays a major role in cardiac muscle contraction. Mutations in MYH7 gene cause hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), endocardial fibroelastosis, left ventricular noncompaction and Ebstein's anomaly. Skeletal muscle disease due to mutations in MYH7 gene include Laing's distal myopathy, myosin storage myopathy, hyaline body myopathy and multiminicore disease.

Inherited HCM is the most common cause of sudden death in young age. It is characterized by unexplained left ventricular (LV) hypertrophy (thickening) associated with non-dilated ventricular chambers. It has a prevalence of about 1 in 500 in the adult population. Greater disease penetrance, more severe hypertrophy, and higher risk of sudden cardiac death are associated with mutations in MYH7 when compared to mutations in other sarcomeric genes. MYH7 mutations account for approximately 33% of inherited hypertrophic cardiomyopathy.

DCM is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. DCM is the most common cause of congestive heart failure in young patients, although, impaired conduction, syncope and sudden death may also occur. It affects 1 per 2,500 in the adult population. MYH7 mutations account for about 4% of inherited DCM.

  • As an aid in diagnosis of familial hypertrophic cardiomyopathy and dilated cardiomyopathy
  • Carrier screening for relatives and those with the family history
  • Prenatal carrier screening for those with the family history
Mutation or pathogenic variant in MYH7 gene. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Negative for mutations analyzed (No pathogenic variant or mutation detected)

Target sequencing by next generation sequencing (NGS, full gene sequencing including deletion/duplication analysis by NGS, deletion/duplication analysis by quantitative multiplex PCR, long-range PCR, multiplex ligation dependent probe amplification (MLPA).

Whole blood (EDTA), Buccal Swab.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Creatine kinase (CK), CK-MB, lactate dehydrogenase (LDH), troponin T, myosin light chain-1 (MLC-1), electrocardiogram, chest X-ray, exercise stress echocardiography, cardiac catheterization and magnetic resonance imaging (MRI).
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Int Heart J. 2019 Nov 30;60(6):1415-1420. [PMID: 31735781]
  • Mol Med Rep. 2019 Dec;20(6):5229-5238. [PMID: 31638223]
  • J Am Coll Cardiol. 2004;44: 602-10. [PMID: 15358028]
  • Eur Heart J. 2017;38: 3461-3468. [PMID: 28082330]
  • Front Physiol. 2016;7: 499. [PMID: 27840609]
  • J Hum Genet. 2016;61: 41-50. [PMID: 26178429]
  • BMC Med Genet. 2014;15: 99. [PMID: 25224718]
  • Anat Rec (Hoboken). 2014;297: 1670-80. [PMID: 25125180]
  • J Am Coll Cardiol. 2004;44: 2390-7. [PMID: 15607403]
  • MYH7. Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/MYH7# The Heart in systemic autoimmune diseases, In: organ-specific autoimmunity involvement in cardiovascular disease. 2017: 31-62. doi:10.1016/b978-0-12-803997-7.00002-8